Lin BioScience Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Market Capitalization	13,319	10,812	8,946	12,583	12,832	6,987	Upgrade
Market Cap Growth	54.92%	20.85%	-28.90%	-1.94%	83.66%	284.89%	Upgrade
Enterprise Value	10,643	8,497	7,788	11,314	11,817	6,797	Upgrade
Last Close Price	161.00	136.58	113.24	170.33	180.59	99.04	Upgrade
PB Ratio	2.49	2.02	2.61	7.25	28.33	7.68	Upgrade
P/TBV Ratio	4.87	3.95	4.41	11.18	28.87	8.60	Upgrade
Debt / Equity Ratio	0.01	0.01	0.01	0.03	0.01	0.01	Upgrade
Quick Ratio	40.31	33.66	23.70	20.60	1.72	3.56	Upgrade
Current Ratio	41.18	34.45	24.69	20.94	1.74	3.62	Upgrade
Return on Equity (ROE)	-36.34%	-28.66%	-41.08%	-41.98%	-70.57%	-28.85%	Upgrade
Return on Assets (ROA)	-24.81%	-19.97%	-25.16%	-20.05%	-19.74%	-16.78%	Upgrade
Return on Capital (ROIC)	-25.40%	-20.57%	-26.09%	-24.87%	-30.86%	-21.87%	Upgrade
Earnings Yield	-7.69%	-6.88%	-7.68%	-2.49%	-3.39%	-2.17%	Upgrade
FCF Yield	-8.70%	-9.48%	-11.34%	-3.05%	-2.27%	-2.59%	Upgrade
Buyback Yield / Dilution	-3.74%	-6.24%	-3.14%	-4.27%	-10.73%	-4.42%	Upgrade

Updated Aug 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.